The MosaiQ solution is a next-generation IVD solution for autoimmune diseases, allergies and beyond. The multiplexed, fully automated planar microarray platform enables syndromic testing for complex ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Autoimmune IVD Testing Market" report to their offering. This report provides important business planning information ...
HERSHEY, Pa. — A new advanced artificial intelligence (AI) algorithm may lead to better — and earlier — predictions and novel therapies for autoimmune diseases, which involve the immune system ...
Selventa today announced that it is developing a powerful new class of diagnostic test that will accelerate the implementation of personalized healthcare. Systems Diagnostics, or SysDx™, will be a ...
"Warm Autoimmune Hemolytic Anemia (wAIHA) Pipeline Analysis"Warm Autoimmune Hemolytic Anemia (wAIHA) companies are Fostamatinib, Immunovant Sciences GmbH, Apellis Pharmaceuticals, Inc., Bioverativ, ...
CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the validation and regulatory submission for approval of new Systemic Lupus ...
ASMAs were first discovered in 1965 in people with chronic active hepatitis. Usually, your immune system will attack foreign bodies like a parasite or a virus with the antibodies made for defending ...
Autoimmune rheumatic diseases (ARDs) represent a diverse group of conditions in which the immune system mistakenly targets the body’s own tissues, often affecting the musculoskeletal system and ...
One growth driver includes the rising prevalence of autoimmune diseases. The global autoimmune disease testing market is estimated to reach $12.1b by 2033 at a compound annual growth rate of 8.6%, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback